Improving Wound Care Healing through Innovation

Our goal is to improve lives through leading-edge advancements in biomaterials science and medical device technologies.

We are committed to innovating new human keratin-based healthcare technologies in order to provide patients and healthcare providers with highly effective wound therapies. Cell Constructs specializes in developing wound care technologies within a global context such that our solutions fit into healthcare practices across the socioeconomic spectrum.

Company History

Cell Constructs is a regenerative healthcare company dedicated to improving wound care healing, leveraging proprietary medical device technologies and biotechnology research and development. There are approximately 350 million people worldwide with diabetes, with up to 90 million people affected in the U.S. and Europe alone. Of these, it’s estimated that 14 million people suffer from chronic wounds annually. Complications from chronic wounds can lead to debilitating and life-threatening complications as well as increased healthcare costs.1 The Company’s first device, ProgenaMatrix™, is an active wound care solution utilizing human keratin. The company was founded in 2008 by experienced scientists from biotechnology and medical device disciplines and is headquartered in Marietta, Georgia, U.S.A.

1. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med 2017;376:2367-7.

Connect with Us

ProgenaMatrix™ is a medical device cleared by the US FDA for the treatment of dry and exuding partial and full thickness wounds.

Copyright ©2019, Cell Constructs I, LLC. All rights reserved.